Here is the caveat that most consumer articles omit: the tripeptide in that landmark study was AHK-Cu L-alanyl-L-histidyl-L-lysine copper, sometimes labeled copper tripeptide-3 not GHK-Cu
Rifamycin SV inhibited OATP2B1-mediated transport of E-3-S and rosuvastatin with similar IC 50 values at pH 6.0 and 7.4, suggesting that the inhibitor affinity is not pH-dependent
The body of evidence across multiple studies in various countries is conclusive that treatment with GLP-1 medications for type 2 diabetes and/or overweight/obesity is strongly associated with an elevated risk of developing NAION
In addition, IL4R is highly expressed in M2-polarized, protumoral TAMs compared with M1-polarized, antitumoral macrophages, making IL4R a potential target for targeted drug delivery to TAMs 31,32
Indeed, decreased activity of mGPDH or the glycerol-3-phosphate shuttle is associated with type 2 diabetes in both rodents [22, 23] and humans [24]